Cytokinetics Incorporated (CYTK) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cytokinetics Incorporated  (NASDAQ: CYTK)


Cytokinetics Incorporated's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Cytokinetics Incorporated's ROA in the second quarter of 2026?
Cytokinetics Incorporated recorded a cumulative net loss of $-894 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -47.65%.

However, within the Healthcare sector 603 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4047, from total ROA ranking in the first quarter of 2026 at 4687.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 174.83 % 0.68 % 1.55 % 0.01 % -19.6 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -894 -830 -785 -752 -606
Return On Assets (TTM) -47.65 % -61.9 % -58.66 % -56.42 % -45.5 %
CYTK's Total Ranking # 4047 # 4687 # 4089 # 4030 # 4068
Total Assets (TTM) in million 3,369 1,273 1,425 1,437 1,226
Seq. Total Assets Change 164.57 % -10.6 % -0.88 % 17.23 % -3.08 %
Seq. Net Income Change - - - - -

CYTK's 5 Years Annual ROA >> Back to CYTK Management Effectiveness >> Compare CYTK ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 268
Sector # 604
Overall # 3979

Return On Assets Statistics
High Average Low
12.02 %
-40.56 %
-67.32 %
(Dec 31 2016)   (Mar 31 2024)





Financial Statements
Cytokinetics Incorporated's Assets $ 3,369 million CYTK's Balance sheet
Cytokinetics Incorporated's Income $ -199 million Quarterly CYTK's Income Statement
CYTK's Income by Division See CYTK's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 25.43 % 69.97 % -18.71 % 20.69 % 57.61 %
Total Assets in million 1,760 1,403 825 1,015 841
Y / Y Net Income Change - - - - -
Net Income in million -785 -590 -526 -389 -215
Annual Return On Assets -44.61 % -42.02 % -63.76 % -38.31 % -25.59 %

CYTK's 5 Years Annual ROA >> Back to CYTK Management Effectiveness >> Compare CYTK ROA to its Competitors



More Return On Assets Ratios
CYTK's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CYTK's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CYTK's Competitors
Subscribers only: Roa for Cytokinetics Incorporated's Suppliers
Subscribers only: Return On Assets for CYTK's Customers

You may also want to know
CYTK's Roi CYTK's Inventory Turnover Ratio CYTK's Growth Rates CYTK's Dividend Comparisons
CYTK's Profitability Ratios CYTK's Asset Turnover Ratio CYTK's Dividend Growth
CYTK's Roe CYTK's Valuation Ratios CYTK's Financial Strength Ratios CYTK's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-08T01:13:25+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.